FDA Inspection
Novo Nordisk US Bio Production Inc.Novo Nordisk US Bio Production Inc. – FDA Inspection, Aug 24, 2018
Record Details
This FDA Inspection record concerns Novo Nordisk US Bio Production Inc., with an inspection on August 24, 2018, issued by the New England District Office, covering biologics.
- People
- Andrey G. Sarafanov (Issuing Officer)
- Ellen A. Huang (Issuing Officer)
- Hector A. Carrero (Investigator)
- Michele L. Forster (Investigator)
- Obinna R. Echeozo
View Company Profile
ID · ef10d29d-5777-4d7d-94bd-d1f7c5119948
Inspection Facts
- Inspection number
- 1064794
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Novo Nordisk US Bio Production Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 9, 2025 | Not classified | New England District Office | |
| March 5, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 25, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novo Nordisk US Bio Production Inc.
- FDA Inspection 1292060 - 2025-12-09
- FDA Inspection 1255809 - 2025-03-05
- FDA Inspection 1214482 - 2023-07-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.